Figures & data
Figure 2. The results of molecular weight determination by MALDI-TOF/TOF-MS. The value marked near the peak is the molecular weight. (A) OVA; (B) coating antigen (arecaidine-OVA); (C) KLH; (D) immunogen (arecaidine-KLH).
![Figure 2. The results of molecular weight determination by MALDI-TOF/TOF-MS. The value marked near the peak is the molecular weight. (A) OVA; (B) coating antigen (arecaidine-OVA); (C) KLH; (D) immunogen (arecaidine-KLH).](/cms/asset/ffb71a02-a5f5-4342-b841-19bf70f6d8e0/cfai_a_2025347_f0002_ob.jpg)
Table 1. Cross reactivity of arecoline and related alkaloids to the mAb-A5H12 in the icELISA.
Figure 3. Standard inhibition curve for arecoline by icELISA. Each point represents the average data for three determinations ± standard deviations. B0 and B denote the absorbance at 450 nm in the absence and presence of arecoline, respectively. The R2 value is 0.99,917.
![Figure 3. Standard inhibition curve for arecoline by icELISA. Each point represents the average data for three determinations ± standard deviations. B0 and B denote the absorbance at 450 nm in the absence and presence of arecoline, respectively. The R2 value is 0.99,917.](/cms/asset/5def1618-2bce-4a11-ba78-987daa7a47ca/cfai_a_2025347_f0003_oc.jpg)
Table 2. The effects of methanol content in sample diluent in icELISA.
Table 3. The recoveries of arecoline determined by icELISA in spiked areca nut leaves, pericarp and endosperm samples (n = 3).
Table 4. Arecoline concentrations in traditional Chinese medicines tested by icELISA and HPLC (n = 3, the receipts of these medicines are shown in supplementary ).
Table 5. Arecoline concentrations of fresh areca nuts tested by icELISA and HPLC (n = 3).